You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infliximab

Showing 51 - 75 of 774
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IBD Trial in Kiel (Infliximab, Vedolizumab)

Completed
  • IBD
  • Kiel, Germany
    Medical Department I, University Hospital Schleswig-Holstein
Jun 30, 2022

Uveitis, Infliximab Trial (infliximab)

Active, not recruiting
  • Uveitis
  • Infliximab
  • infliximab
  • (no location specified)
Oct 28, 2021

Crohn Disease Trial in Worldwide (Infliximab, Placebo)

Completed
  • Crohn Disease
  • Infliximab
  • Placebo
  • Aarhus, Aarhus C, Denmark
  • +12 more
Mar 9, 2022

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy, Retinal Detachment Trial in Cairo (Intravitreal infliximab,

Recruiting
  • Rhegmatogenous Retinal Detachment
  • +2 more
  • Intravitreal infliximab
  • Pars plana vitrectomy
  • Cairo, Egypt
    Cairo University
Nov 26, 2021

Combined Microbiota and Metabolic Signature in Ulcerative

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jan 26, 2023

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

Covid19, Coronavirus Disease 2019, SARS-CoV-2 Acute Respiratory Disease Trial in Helsinki (Imatinib, Infliximab)

Recruiting
  • Covid19
  • +2 more
  • Helsinki, Finland
    University of Helsinki
Apr 27, 2022

Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)

Completed
Has Results
  • Kidney Transplant
  • Infliximab
  • +9 more
  • Birmingham, Alabama
  • +14 more
Jul 19, 2022

Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

Not yet recruiting
  • Crohn Disease
  • TNFa Antagonist - Infliximab
  • +5 more
  • Calgary, Alberta, Canada
    University of Calgary
Jun 22, 2023

Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe, Rectal Ulcer Trial in Xi'an (other, drug, biological)

Not yet recruiting
  • Ulcerative Colitis Chronic Moderate
  • +2 more
  • Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment
  • +3 more
  • Xi'an, Shaanxi, China
    Xijing Digestive Disease
Jun 12, 2023

Ulcerative Colitis Trial in Peta? Tiqwa (Infliximab)

Terminated
  • Ulcerative Colitis
  • Infliximab
  • Petaẖ Tiqwa, Israel
    Schenider Children's Medical Center
Sep 25, 2021

Subcutaneous Infliximab Levels.

Completed
  • Inflammatory Bowel Diseases
    • Sevilla, Spain
      Hospital Universitario Virgen Macarena
    Nov 15, 2021

    Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)

    Recruiting
    • Axial Spondyloarthritis
    • Tapered doses of TNFi
    • Standard dose of TNFi
    • Toronto, Ontario, Canada
      University Health Network - Toronto Western Hospital
    Nov 21, 2022

    Crohn Disease Trial in Paris (Infliximab CT-P13, Immunosuppressors (Thiopurines or Methotrexate))

    Recruiting
    • Crohn Disease
    • Infliximab CT-P13
    • Immunosuppressors (Thiopurines or Methotrexate)
    • Paris, France
      GETAID
    Aug 2, 2022

    Rheumatoid Arthritis Trial in Shanghai (Infliximab)

    Completed
    • Rheumatoid Arthritis
    • Infliximab
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital
    Oct 8, 2021

    Melanoma Stage III, Melanoma Stage IV, Side Effect of Drug Trial in Boston (Infliximab, Methylprednisolone, Prednisone)

    Recruiting
    • Melanoma Stage III
    • +3 more
    • Infliximab
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 26, 2021

    Extrathoracic Sarcoidosis Trial in France (Infliximab, Placebo)

    Completed
    • Extrathoracic Sarcoidosis
    • Infliximab
    • Placebo
    • Bobigny, France
    • +9 more
    Nov 15, 2021

    Ulcerative Colitis Trial in Portugal, Spain (Adacolumn)

    Recruiting
    • Ulcerative Colitis
    • Adacolumn
    • Coimbra, Portugal
    • +9 more
    Jun 22, 2022

    Molecular Signatures in Inflammatory Skin Disease

    Recruiting
    • Atopic Dermatitis
    • Psoriasis
    • Kiel, Germany
      Department of Dermatology, University Hospital Schleswig Holstei
    Jul 16, 2022

    Crohn Disease Trial in Cincinnati (RoadMAB)

    Recruiting
    • Crohn Disease
    • RoadMAB
    • Cincinnati, Ohio
      Cincinnati Children's Hospital
    Oct 19, 2021

    Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)

    Recruiting
    • Ulcerative Colitis
    • Miami, Florida
    • +1 more
    Apr 22, 2022

    Blood Platelet Indices,Platelet Aggregation in Activity of IBD

    Not yet recruiting
    • Bowel Disease
    • Inflammatory Bowel Diseases
    • Infliximab
    • (no location specified)
    Jun 4, 2022

    TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer

    Completed
    • Rheumatoid Arthritis
    • Boston, Massachusetts
      Brigham And Women's Hospital
    Jun 17, 2022

    Pediatric IBD Population

    Recruiting
    • Inflammatory Bone Disease
    • Infliximab Assay
    • Detroit, Michigan
      Children's Hospital of Michigan
    Jun 8, 2021

    A Multicentered Prospective Cohort Study of Chinese IBD Patients

    Enrolling by invitation
    • Ulcerative Colitis
    • Crohn Disease
    • Infliximab
    • +3 more
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 17, 2022